دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Meta-analysis of the timing of laparoscopic cholecystectomy after endoscopic retrograde cholangiopancreatography in patients with cholecystolithiasis and choledocholithiasis.
Li, Zhan; Xu, Dong; Yu, Hao; Jiang, Honglei; Jin, Junzhe
doi : 10.1097/MEG.0000000000002553
Volume 35(6) pgs. 619-696 June 2023
AB Endoscopic retrograde cholangiopancreatography (ERCP) combined with laparoscopic cholecystectomy plays an important role in the treatment of cholecystolithiasis combined with choledocholithiasis; however, there is no unified standard for the interval of ERCP before laparoscopic cholecystectomy.
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD).
Principi, Mariabeatrice a; Macaluso, Fabio Salvatore b; Todeschini, Alessia a; Facciotti, Federica c; Contaldo, Antonella d; Castiglione, Fabiana e; Nardone, Olga Maria e; Spagnuolo, Rocco f; Doldo, Patrizia f; Riguccio, Gaia g; Conforti, Francesco Simone h; Vigano, Chiara i; Ascolani, Marta j; Fiorino, Gionata k; Correale, Carmen l; Bodini, Giorgia m; Milla, Monica n; Scardino, Giulia o; Vernero, Marta p; Desideri, Federico q; Caprioli, Flavio i,r; Mannino, Mariella b; Rizzo, Giuseppe b; Orlando, Ambrogio b; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Administration of maximum dose of mucolytic solution before upper endoscopy - a double-blind, randomized trial.
Stepan, Michal a,b,c; Fojtik, Petr a,b; Psar, Robert d,e; Hanousek, Martin a; Sabol, Marek a; Zapletalova, Jana f; Falt, Premysl g
doi : 10.1097/MEG.0000000000002559
The aim of the study was to demonstrate that an administration of mucolytic solution with a maximum dose of simethicone and N-acetylcysteine before upper endoscopy improves mucosal visibility compared to a group without administration of mucolytic solution or water.
Exercise habits that include exercise partners and irritable bowel syndrome in a young Japanese population: a cross-sectional study.
Yamamoto, Yasunori a,*; Furukawa, Shinya b,*; Miyake, Teruki c; Watanabe, Junichi d; Kato, Aki b; Kusumoto, Katsunori b; Takeshita, Eiji e; Ikeda, Yoshio a; Yamamoto, Naofumi f; Saeki, Yuka b,g; Hiasa, Yoichi c
doi : 10.1097/MEG.0000000000002561
Evidence regarding the association between exercise habits and irritable bowel syndrome (IBS) remains scarce in a young population. It is also unknown whether the existence of an exercise partner affects this issue.
Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis.
Tarar, Zahid Ijaz a; Farooq, Umer b; Gandhi, Mustafa a; Ghous, Ghulam a; Saleem, Saad c; Kamal, Faisal d; Imam, Zaid e; Jamil, Laith e
doi : 10.1097/MEG.0000000000002568
Radiofrequency ablation (RFA) is used in addition to stent placement to manage extrahepatic malignant biliary obstruction. We aimed to study the effect of RFA on overall survival (OS) and stent patency in malignant biliary obstruction.
Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients.
Sourianarayanane, Achuthan a; McCullough, Arthur J b
doi : 10.1097/MEG.0000000000002544
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing in the USA. Some of these patients develop non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis.
Non-alcoholic fatty liver disease is associated with an increased risk of type 2 diabetes.
Loosen, Sven H. a,*; Krieg, Sarah a,*; Krieg, Andreas b; Qvartskhava, Natalia a; Luedde, Tom a; Kostev, Karel c,#; Roderburg, Christoph a,#
doi : 10.1097/MEG.0000000000002555
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease worldwide and represents the leading cause of liver-related morbidity and mortality. Its all-cause mortality is often driven by co-existing metabolic diseases such as type 2 diabetes (T2DM), which share many pathophysiological characteristics.
Pathogenic factors of cognitive dysfunction after liver transplantation: an observational study.
Zhou, Yongpeng a; Huang, Jun b; Si, Zhongzhou c; Zhou, Qin d; Li, Liwen d
doi : 10.1097/MEG.0000000000002551
Neurocognitive complications significantly reduce long-term health-related quality of life in patients undergoing liver transplantation; however, few studies have focused on their perioperative cognitive status.
Outcome of pharmacological thromboprophylaxis in hospitalized patients with cirrhosis - a systematic review and meta-analysis.
Giri, Suprabhat a; Singh, Ankita b; Varghese, Jijo c; Ingawale, Sushrut d; Roy, Akash e
doi : 10.1097/MEG.0000000000002564
Portal hypertension in cirrhosis brings about a complex interplay in the risks of bleeding and thrombosis. It is unclear whether hospitalized patients with cirrhosis need pharmacological prophylaxis for venous thromboembolism (VTE), as it may increase the risk of bleeding.
Correlation between individual autoantibodies and clinical features in primary biliary cholangitis: results of a retrospective longitudinal study.
Dias, Beatriz a; Aguiar, Ana a,b,c; Morais, Catia Iracema a,d; Nery, Filipe Gaio a,b,c,e
doi : 10.1097/MEG.0000000000002565
Primary biliary cholangitis (PBC) is an immune-mediated liver disease. The immunological profile seems to relate to clinical prognosis.
Paper Alert.
doi : 10.1097/MEG.0000000000002570
AB A selection of interesting papers that were published in the month before our press date in major journals likely to report important results in gastroenterology and hepatology. Peter Hayes and John Plevris The Royal Infirmary, Edinburgh EH3 9YW, UK Copyright (C) 2023 Wolters Kluwer Health, Inc. All rights reserved.
